Save the date for the online workshop by EuroStemCell. More information coming shortly
REGISTRATION IS NOW OPEN
EULAC-Permed will be hosting their second technical workshop. This workshop aims to address the ethical, legal and social aspects in personalised medicine.
Objective of the workshop: To exchange insights on key ethical, legal and social issues in personalised medicine (PM) research and implementation in Europe and in Latin America and the Caribbean (LAC) and identify recommendations for future bi-regional collaborations in the field of PM.
The 3rd Annual Summer School hosted by EULAC-Permed is going virtual. It will address the implementation research in personalised medicine: ethical, legal and social aspect perspective.
Applications are now open until October 7th.
For more information visit the website
The event will take place on February 25-26, 2021 in Paris, France, at La Maison de la Chimie and will demonstrate how personalised medicine will lead to the next generation of healthcare by 2030.
ECRIN's celebration of International Clinical Trials Day (ICTD) will be held on May 27th, 2021 in Berlin (Langenbeck-Virchow-Haus Berlin, Luisenstraße 58/59, 10117 Berlin, Germany). The topic will be (patient-)recruitment in clinical trials. More details to come!
The Clinical Research Initiative for Global Health (www.crigh.org) aims to support international collaboration on clinical research by developing global standards and establishing a collaborative framework to address health issues worldwide.
The main objectives of this year Symposium are:
- to show the value of EOSC to research performing organisations and research funders;
- to onboard new members into the EOSC Association;
- to engage the EOSC providers explaining how and why federate the services with the objectives.
Registration is now open through to October 13th.
For more details visit the website
Registration is now open for the 6th Annual Trial Methodology Symposium. This year the theme is Improved trials for better health decisions for an informed public.
ECRIN's Director General, Jacques Demotes, will be discussing the role of multinational cooperation and new trial methodologies in improved health decisions.
For more information and the full program visit the website
Active engagement of conference participants is expected to discuss challenges and identify solutions on what could be done to optimise children’s access to new medicines:
- What data sources and digital technologies could bring to paediatric development on top of the use of extrapolation?
- How to best define children unmet medical needs?
- How to optimise the PIP process and regulatory approval
The conference will also explore what drug development means for Paediatricians, and in particular during COVID-19 pandemic.